InsidersTradesSigma
Ajanta Pharma Limited: insider trades · India · SEBI (PIT + SAST)
SEBI:ajanta-pharma-limitedIN·SEBI (PIT + SAST)Mcap 350.3Bn€
Discover the full directors' dealings record of Ajanta Pharma Limited, a publicly traded company based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €350.3bn. The latest transaction was reported on 13 March 2026 (Sale). Among the most active insiders: Ravi P Agrawal, trustee Ravi Agrawal Trust. Every trade is accessible without an account.
229
Insider Decl.
0
Thresholds
€25,087
24 ops.
Buy Volume
€90m
82 ops.
Sell Volume
Financial data
FY ended March 2026 · cache
3214.10 €
Income statement
Revenue54.53 Bn€
Gross profit42.69 Bn€78% margin
Net income10.56 Bn€19.4% margin
Balance sheet & cash
Market cap350.26 Bn€
Total debt2.60 Bn€
Free Cash Flow1.64 Bn€
Last declaration on 13 March 2026
Declarations229 total
Executives●Sale4SEBI
€17,665607 shares@ €29.10140.0000% mcap6.7% of flow
Equity Shares
SEBI:09f83c50e1bac8e6003c99c5247da57a14155d52·
Executives●Sale0SEBI
€19,223750 shares@ €25.6305
Equity Shares
SEBI:1dcb887468b5d4a74fb919411c27e99e7893a57e·
Executives●Sale0SEBI
€73,9343,000 shares@ €24.6446
Equity Shares
SEBI:7a5683ef306d063ae8f127f6c5f38c223198f465·
Executives●Sale0SEBI
€50,0152,000 shares@ €25.0076
Equity Shares
SEBI:b8a8da2a9bbe096359fd6d548efbdff8ec27f242·
Executives●Sale0SEBI
€23,038900 shares@ €25.5976
Equity Shares
SEBI:236dcc9589a0e4d020fc29f52ef6da0a24753cc4·
Executives●Sale0SEBI
€16,309548 shares@ €29.7618
Equity Shares
SEBI:ce751f9aa0fac774fd6ff216cc053d2f3eb8b27e·
Executives●Sale0SEBI
€3,360100 shares@ €33.597
Equity Shares
SEBI:81aaeec7dc43066be3e1e9f9ab61c9b6f3488d33·
Executives●Sale0SEBI
€1,68351 shares@ €33.0088
Equity Shares
SEBI:e850b263b0dd81b8e4f70577e477cf6e5d5372fe·
Executives●Sale0SEBI
€3,311100 shares@ €33.1108
Equity Shares
SEBI:63707ea004b3312b57ff88d5dab7715d4df49aee·
Executives●Sale0SEBI
€1,63749 shares@ €33.4152
Equity Shares
SEBI:a66349f94b664e7d90294b63148de2daadf02e93·
Executives●Sale0SEBI
€3,246100 shares@ €32.4587
Equity Shares
SEBI:8b3dfe0f8172ec65bf734b1c670522b5e8ac5e3a·
Executives●Sale0SEBI
€175,9825,000 shares@ €35.1964
Equity Shares
SEBI:6570272c6b41a68967d6776410445a268276c18b·
Executives●Purchase0SEBI
€221,000 shares@ €0.0218
Equity Shares
SEBI:11ec1415cb1adfc8c0d977492e9f742ea4f15d22·
Ideal exit: 4 May 2025 (T+270)
Executives●Sale0SEBI
€211,5896,000 shares@ €35.2648
Equity Shares
SEBI:fff1b22265f57a362728b1d5e6ead4536a9d8b10·
Executives●Sale0SEBI
€6,101200 shares@ €30.5063
Equity Shares
SEBI:0531eeee2c1db1c00ff80caa97ece38e38c2e597·
Executives●Purchase0SEBI
€11500 shares@ €0.0218
Equity Shares
SEBI:5cbe99ce6cbf67e25ee89b99d9323502a0a1814a·
Ideal exit: 4 May 2025 (T+270)
Executives●Sale0SEBI
€3,194100 shares@ €31.9382
Equity Shares
SEBI:c575c82d88eef26ee0b5df9f62a647a1532482ea·
Executives●Sale0SEBI
€3,439100 shares@ €34.3936
Equity Shares
SEBI:fe16aa19b56694fbc2cab3ec627b4c1f21fbbc53·
Executives●Pledge0SEBI
€6m169,983 shares@ €34.4035
Equity Shares
SEBI:83532c4a739214a70ac7e432bbe4217ff0c086ce·
Executives●Pledge0SEBI
€58517 shares@ €34.4031
Equity Shares
SEBI:07e65346a53f5045ad84f913bbaf464b14febef1·
Executives●Pledge0SEBI
€288,4819,000 shares@ €32.0535
Equity Shares
SEBI:ae4f299e41876841684ab08e9caae416010d7d0f·
Executives●Sale0SEBI
€64,3462,000 shares@ €32.173
Equity Shares
SEBI:6a957e81a17a02247d3e9d58b71dadd7cb1d6f5a·
Executives●Pledge0SEBI
€12m450,000 shares@ €25.923
Equity Shares
SEBI:a2d1ba2b5d42123ea599659992d05b220461695a·
Executives●Sale0SEBI
€22,220720 shares@ €30.8606
Equity Shares
SEBI:daf440a3739d76cc9a9a1f65b3cadd34ceaed933·
Executives●Sale0SEBI
€2m76,818 shares@ €30.8606
Equity Shares
SEBI:64ac3d3b887e16a44c782267cfa2427cc0db41ac·
25 of 229 declarations
About Ajanta Pharma Limited
Ajanta Pharma Limited is an Indian pharmaceutical company specializing in the manufacture of generic drugs and healthcare products. It is listed on the Bombay Stock Exchange.